MSCI China USA Biotech 65/35 Index

The MSCI China USA Biotech 65/35 Index aims to represent the performance of securities from MSCI Hong Kong Listed Southbound IMI Index and MSCI USA IMI Index with exposure to the GICS® Biotechnology Industry.
Index code
766405
Index type
Equity
Benchmark administrator
--
Div Yld (%)
0.66
P/E
47.30
P/E Fwd
40.92
P/BV
6.16
Number of constituents
37
Index Market Cap
$1.56 T
Largest constituent Market Cap
$198.31 B
Smallest constituent Market Cap
$2.82 B
Average constituent Market Cap
$42.26 B
Median constituent Market Cap
$15.57 B
Does this benchmark pursue ESG objectives?
N/A*
Data as of Sept. 30, 2026 
* For ESG objective information, please see this page

Want to learn more about MSCI indexes?
Get in touch.